Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study document revision was updated to v3.5.4, replacing the previous v3.5.3. This reflects a newer version of the protocol without additional visible content changes in the data provided.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe location entry has been updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305 in the Locations section. This clarifies the city designation for that site in the ATHENA study record.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page shows a Revision tag updated to v3.5.3, indicating a software revision. The study details and visible content appear unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check60 days agoChange DetectedIn the Locations section, the Abbotsford entry is reformatted from 'Abbotsford, British Columbia, Canada, V2S 0C2' to 'Abbotsford British Columbia, British Columbia, Canada, V2S 0C2'.SummaryDifference0.0%

- Check68 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list. The revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.